KBC Group
IOVA icon

KBC Group’s Iovance Biotherapeutics IOVA Stock Holding History

KBC Group’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34K Buy
+9,586
New +$30.7K ﹤0.01% 1766
2025
Q2 		– Sell
-12,303
Closed -$41K – 1762
2025
Q1 		$41K Hold
12,303
– – ﹤0.01% 1822
2024
Q4 		$91K Buy
12,303
+6,321
+106% +$58.6K ﹤0.01% 1621
2024
Q3 		$56K Hold
5,982
– – ﹤0.01% 1656
2024
Q2 		$48K Buy
5,982
+1,607
+37% +$17.2K ﹤0.01% 1646
2024
Q1 		$65K Sell
4,375
-198
-4% -$2.31K ﹤0.01% 1381
2023
Q4 		$37K Hold
4,573
– – ﹤0.01% 1708
2023
Q3 		$21K Buy
+4,573
New +$29.9K ﹤0.01% 1876
2020
Q4 		– Sell
-1,200
Closed -$40K – 1276
2020
Q3 		$40K Hold
1,200
– – ﹤0.01% 1214
2020
Q2 		$32K Buy
1,200
+600
+100% +$19.7K ﹤0.01% 1255
2020
Q1 		$18K Hold
600
– – ﹤0.01% 1257
2019
Q4 		$17K Buy
600
+380
+173% +$8.64K ﹤0.01% 1460
2019
Q3 		$4K Hold
220
– – ﹤0.01% 1469
2019
Q2 		$5K Buy
+220
New +$3.31K ﹤0.01% 1449

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return